Cerebras Systems focuses on building specialized hardware and software to handle the heaviest AI workloads. Instead of relying on clusters of smaller chips, the company developed a single, wafer-sized processor that it claims can deliver better performance and efficiency than standard GPUs for training large models and running inference. I follow CBRS closely because it operates right in the middle of the surging demand for AI computing capacity, going up against much larger semiconductor names.
Founded to address the growing need for faster AI hardware, Cerebras is based in Sunnyvale, California, and operates in the semiconductor space. Co-founder and CEO Andrew Feldman leads a team with deep experience in high-performance computing. The company went public on Nasdaq under the ticker CBRS in May 2026. Its systems are designed for data-center use, from single racks to large-scale clusters, and can be deployed on-premises or accessed via the cloud.
The centerpiece of Cerebras’s approach is the Wafer-Scale Engine (WSE). Traditional manufacturing cuts wafers into many small chips, but Cerebras keeps nearly the entire wafer as one massive processor to cut down on communication delays between separate GPUs. These processors come as complete systems that include cooling, supporting hardware, and software. Revenue comes mainly from selling these integrated AI compute systems and from cloud access to the capacity. Customers range from hyperscalers and large enterprises to government agencies and research institutions.
Cerebras competes in a tough field led by NVDA (NVIDIA) and other players such as AMD. The wafer-scale design is positioned as offering speed and efficiency gains for very large models and inference workloads. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry. Financially, the company shows rapid revenue growth but remains unprofitable, with heavy spending on research and expansion. Investors tend to watch revenue trends, gross margins, and the pace of commercial adoption rather than traditional profit metrics.
Interest centers on the broad expansion of AI, where larger models drive demand for specialized hardware. Cerebras’s architecture stands out as one of the few commercial alternatives aimed at the high-performance end. The company’s ability to support both on-premises and cloud deployments adds flexibility, while its emphasis on inference aligns with the shift toward production use of AI models. From what I see, progress on customer relationships and converting design wins into recurring revenue will be key watch points.
Several factors warrant caution. Cerebras faces much larger rivals with established ecosystems and deeper resources. It continues to report net losses and must fund ongoing development while scaling operations. Customer concentration adds another layer of risk, as a handful of large buyers can represent a significant portion of revenue. Supply-chain issues, geopolitical tensions in semiconductors, and fast-moving technology changes are also relevant. With a limited public track record since the 2026 IPO, the available history for evaluation is shorter than for more established names.
When analyzing names like CBRS, I often turn to Tickeron’s AI-powered platforms to cross-check signals and compare opportunities across the market. The AI Screener, in particular, helps filter thousands of stocks by technical indicators, fundamentals, and AI-generated insights, which can surface ideas that align with a specific strategy. It has become a regular part of how I narrow down research efficiently.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where CBRS declined for three days, in 28 of 28 cases, the price declined further within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for CBRS entered a downward trend on November 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 5 of 5 cases where CBRS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.
The Moving Average Convergence Divergence (MACD) for CBRS just turned positive on November 09, 2026. Looking at past instances where CBRS's MACD turned positive, the stock continued to rise in 1 of 2 cases over the following month. The odds of a continued upward trend are 50%.
Following a +18.34% 3-day Advance, the price is estimated to grow further. Considering data from situations where CBRS advanced for three days, in 17 of 22 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
CBRS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 25 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.327) is normal, around the industry mean (5.443). P/E Ratio (-19.264) is within average values for comparable stocks, (15.640). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.803). Dividend Yield (0.000) settles around the average of (0.014) among similar stocks. P/S Ratio (63.694) is also within normal values, averaging (46.468).
The Tickeron Price Growth Rating for this company is 84 (best 1 - 100 worst), indicating slightly worse than average price growth. CBRS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CBRS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry Semiconductors